Market Specialization BioMed Laboratories focuses on providing contract manufacturing services for wound care, ostomy, and professional skin care markets, indicating opportunities to collaborate with medical device and OTC product companies seeking manufacturing partners in these niche segments.

Quality Credentials With ISO 13485 certification and FDA registration, BioMed demonstrates compliance with high standards for medical device manufacturing, making it an attractive partner for firms looking to ensure quality and regulatory adherence in their supply chain.

Acquisition Potential Having been acquired by Scapa Group in 2018 for $19M suggests recent consolidation activity; sales efforts could target similarly sized companies or divisions seeking strategic manufacturing partners to expand or streamline their operations.

Growth Opportunity Operating with revenue between $1M and $10M, BioMed presents an opportunity for phase-based growth engagements, such as offering specialized services to larger, established pharmaceutical or medical product companies aiming to outsource niche product manufacturing.

Technology Utilization Employing a robust tech stack with tools like Google Cloud, Google Analytics, and Nginx showcases a modern, scalable infrastructure, which can be leveraged to support innovative production methods or digital solutions in contract manufacturing collaborations.